Vimarsana
Biggest News Aggregation in the World

Page 32 - Accessed May News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed May Today - Breaking & Trending Today

APA hosts annual meeting in San Francisco - Vimarsana News

APA hosts annual meeting in San Francisco

SAN FRANCISCO — The American Psychiatric Association is hosting its annual meeting in San Francisco with the theme “Innovate, collaborate, motivate: Charting the future of mental health.”

Source: healio.com
Managing Total Knee Replacement Under Value-Based Payments - Vimarsana News

Managing Total Knee Replacement Under Value-Based Payments

This article describes the approach that a large primary care group at risk for value-based payments chose to deploy in managing clinical and financial outcomes of knee osteoarthritis jointly with orthopedic surgeons.

Source: ajmc.com
Febrile toddler presents with painful neck mass - Vimarsana News

Febrile toddler presents with painful neck mass

A 16-month-old girl presents with a painful neck mass and fever. Her mother states that she has always had a “fullness” in the front of her neck, which suddenly increased in size.

Source: healio.com
Challenges in Reimbursement for Pharmacy Services, DIR Fees, and the Evolving PBM Model - Vimarsana News

Challenges in Reimbursement for Pharmacy Services, DIR Fees, and the Evolving PBM Model

Amid various obstacles, health care providers and pharmacists can initiate measures to enhance compensation for pharmacy services in managed care.

TAGRISSO® (osimertinib) plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial - Vimarsana News

TAGRISSO® (osimertinib) plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial

Results support potential for a new treatment option that builds on the benefit of first-line standard of care TAGRISSO monotherapy ... | May 17, 2023